Retail Pharmacy Forecast 2022
Chain Drug Review, George Rafferty and Jennifer Zilka
Top industry executives discuss the prospects for their businesses and the sector as a whole for 2022. With the pandemic surging, pharmacy chains are planning for new solutions to fight the variants. At the same time retailers are looking to broaden affordable and accessible health care offerings when many people find such services from more traditional providers out of financial reach. Chains are also bolstering their e-commerce appeal to entice omnichannel shoppers. Top industry executives discuss the prospects for their businesses and the sector as a whole for 2022.
For the full article, please visit Chain Drug Review.